---
title: "Sight Sciences, Inc. (SGHT.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/SGHT.US.md"
symbol: "SGHT.US"
name: "Sight Sciences, Inc."
industry: "Health Care Equipment"
datetime: "2026-05-19T19:34:58.419Z"
locales:
  - [en](https://longbridge.com/en/quote/SGHT.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SGHT.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SGHT.US.md)
---

# Sight Sciences, Inc. (SGHT.US)

## Company Overview

Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases in the United States. The company operates in two segments, Surgical Glaucoma and Dry Eye. It offers OMNI, a surgical system family of products, such as OMNI Ergo for the catheterization and transluminal viscodilation of Schlemm’s canal and cutting of the trabecular meshwork to reduce intraocular pressure in adult patients with open-angle glaucoma; and OMNI EDGE, an implant-free and minimally invasive glaucoma surgery technology. The company also provides SION, a bladeless and manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork; and TearCare system, a proprietary, interventional, dry eye device designed to melt and facilitate the comprehensive removal of meibomian gland obstructions and restore gland functionality and healthy oil production for adult patients with evaporative dry eye disease due to meibomian gland disease when used in conjunction with manual expression of the meibomian glands for ophthalmologists and optometrists.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | US Market |
| Website | [www.sightsciences.com](https://www.sightsciences.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-19T04:30:14.000Z

**Overall: C (0.54)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 75 / 183 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 1.85% |  |
| Net Profit YoY | 24.58% |  |
| P/B Ratio | 4.91 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 264432318.12 |  |
| Revenue | 79553000.00 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -56.64% | E |
| Profit Margin | -46.83% | E |
| Gross Margin | 86.19% | A |
| Revenue YoY | 1.85% | C |
| Net Profit YoY | 24.58% | B |
| Total Assets YoY | -15.41% | E |
| Net Assets YoY | -30.56% | E |
| Cash Flow Margin | 67.43% | C |
| OCF YoY | 1.85% | C |
| Turnover | 0.66 | B |
| Gearing Ratio | 50.86% | C |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Sight Sciences, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "1.85%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "24.58%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "4.91",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "264432318.12",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "79553000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "-56.64%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-46.83%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "86.19%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "1.85%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "24.58%",
          "rating": "B"
        },
        {
          "name": "Total Assets YoY",
          "value": "-15.41%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-30.56%",
          "rating": "E"
        },
        {
          "name": "Cash Flow Margin",
          "value": "67.43%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "1.85%",
          "rating": "C"
        },
        {
          "name": "Turnover",
          "value": "0.66",
          "rating": "B"
        },
        {
          "name": "Gearing Ratio",
          "value": "50.86%",
          "rating": "C"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -7.10 | 133/183 | - | - | - |
| PB | 4.91 | 100/183 | 5.32 | 3.23 | 2.60 |
| PS (TTM) | 3.32 | 77/183 | 4.48 | 2.86 | 2.42 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Delcath (DCTH.US) | C | A | B | A | A | A |
| 02 | Electromed (ELMD.US) | A | B | A | A | B | A |
| 03 | Intuitive Surgical (ISRG.US) | A | B | C | A | B | B |
| 04 | Stryker (SYK.US) | A | C | C | C | B | B |
| 05 | Boston Scientific (BSX.US) | A | B | C | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-14T04:00:00.000Z

Total Analysts: **6**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 3 | 50% |
| Overweight | 1 | 17% |
| Hold | 2 | 33% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 4.74 |
| Highest Target | 12.00 |
| Lowest Target | 4.35 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/SGHT.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/SGHT.US/norm.md)
- [Related News](https://longbridge.com/en/quote/SGHT.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/SGHT.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**